These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 27563232)
1. Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy. Chen H; Zhang X; Liao N; Wen F Mol Vis; 2016; 22():1005-14. PubMed ID: 27563232 [TBL] [Abstract][Full Text] [Related]
2. Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor. Simon D; Denniston AK; Tomlins PJ; Wallace GR; Rauz S; Salmon M; Murray PI; Curnow SJ Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3988-91. PubMed ID: 18469182 [TBL] [Abstract][Full Text] [Related]
3. The IL-6-neutralizing sIL-6R-sgp130 buffer system is disturbed in patients with type 2 diabetes. Aparicio-Siegmund S; Garbers Y; Flynn CM; Waetzig GH; Gouni-Berthold I; Krone W; Berthold HK; Laudes M; Rose-John S; Garbers C Am J Physiol Endocrinol Metab; 2019 Aug; 317(2):E411-E420. PubMed ID: 31237452 [TBL] [Abstract][Full Text] [Related]
4. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling. Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558 [TBL] [Abstract][Full Text] [Related]
5. Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa. Karczewska-Kupczewska M; Adamska A; Nikołajuk A; Otziomek E; Górska M; Kowalska I; Strączkowski M Clin Endocrinol (Oxf); 2013 Dec; 79(6):812-6. PubMed ID: 23199226 [TBL] [Abstract][Full Text] [Related]
6. Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission. Robak T; Wierzbowska A; Błasińska-Morawiec M; Korycka A; Błoński JZ Mediators Inflamm; 1999; 8(6):277-86. PubMed ID: 10815616 [TBL] [Abstract][Full Text] [Related]
7. Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients. Kovacs E Biomed Pharmacother; 2001 Sep; 55(7):391-6. PubMed ID: 11669502 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases. Nikolaus S; Waetzig GH; Butzin S; Ziolkiewicz M; Al-Massad N; Thieme F; Lövgren U; Rasmussen BB; Reinheimer TM; Seegert D; Rosenstiel P; Szymczak S; Schreiber S Int J Colorectal Dis; 2018 Jul; 33(7):927-936. PubMed ID: 29748708 [TBL] [Abstract][Full Text] [Related]
9. Measurements of IL-6, soluble IL-6 receptor and soluble gp130 in sera of B-cell lymphoma patients. Does viscum album treatment affect these parameters? Kovacs E; Kuehn JJ Biomed Pharmacother; 2002 May; 56(3):152-8. PubMed ID: 12046687 [TBL] [Abstract][Full Text] [Related]
10. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes. Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511 [TBL] [Abstract][Full Text] [Related]
11. The balance between soluble receptors regulating IL-6 trans-signaling is predictive for the RANKL/osteoprotegerin ratio in postmenopausal women with rheumatoid arthritis. Oelzner P; Franke S; Lehmann G; Eidner T; Hein G; Wolf G Rheumatol Int; 2012 Jan; 32(1):199-206. PubMed ID: 20821212 [TBL] [Abstract][Full Text] [Related]
12. The IL-6/IL-6R/sgp130 system and Th17 associated cytokines in patients with gestational diabetes. Kuźmicki M; Telejko B; Lipińska D; Pliszka J; Wilk J; Wawrusiewicz-Kurylonek N; Zielińska A; Sobota A; Krętowski A; Górska M; Szamatowicz J Endokrynol Pol; 2014; 65(3):169-75. PubMed ID: 24971916 [TBL] [Abstract][Full Text] [Related]
13. Enhanced IL-6 trans-signaling in pulmonary arterial hypertension and its potential role in disease-related systemic damage. Jasiewicz M; Knapp M; Waszkiewicz E; Ptaszynska-Kopczynska K; Szpakowicz A; Sobkowicz B; Musial WJ; Kaminski KA Cytokine; 2015 Dec; 76(2):187-192. PubMed ID: 26163998 [TBL] [Abstract][Full Text] [Related]
14. Release of interleukin-6 and its soluble receptors by activated peripheral blood monocytes is elevated in hypocholesterolemic hemodialysis patients. Tsirpanlis G; Chatzipanagiotou S; Boufidou F; Kordinas V; Alevyzaki F; Zoga M; Kyritsis I; Ioannou D; Fatourou A; Nicolaou C Am J Nephrol; 2005; 25(5):484-90. PubMed ID: 16127269 [TBL] [Abstract][Full Text] [Related]
15. Response of plasma IL-6 and its soluble receptors during submaximal exercise to fatigue in sedentary middle-aged men. Gray SR; Robinson M; Nimmo MA Cell Stress Chaperones; 2008; 13(2):247-51. PubMed ID: 18320358 [TBL] [Abstract][Full Text] [Related]
16. Plasma IL-6, its soluble receptors and F2-isoprostanes at rest and during exercise in chronic fatigue syndrome. Robinson M; Gray SR; Watson MS; Kennedy G; Hill A; Belch JJ; Nimmo MA Scand J Med Sci Sports; 2010 Apr; 20(2):282-90. PubMed ID: 19422646 [TBL] [Abstract][Full Text] [Related]
17. Soluble glycoprotein 130 is inversely related to severity of coronary atherosclerosis. Korotaeva AA; Samoilova EV; Chepurnova DA; Zhitareva IV; Shuvalova YA; Prokazova NV Biomarkers; 2018 Sep; 23(6):527-532. PubMed ID: 29580104 [TBL] [Abstract][Full Text] [Related]
18. Associations between serum estradiol and IL-6/sIL-6R/sgp130 complex in female patients with major depressive disorder. Sun T; Chen Q; Mei J; Li Y BMC Psychiatry; 2023 Oct; 23(1):742. PubMed ID: 37828513 [TBL] [Abstract][Full Text] [Related]
19. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of systemic IL-6 trans-signalling in patients with primary open-angle glaucoma. Ulhaq ZS; Istifiani LA; Pamungkas SA J Fr Ophtalmol; 2023 Jun; 46(6):622-629. PubMed ID: 37095023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]